Company Quick10K Filing
Quick10K
Cancer Capital
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2018-01-23 Accountant, Exhibits

Cancer Capital Financials

-

CNCL Metrics, Comps, Filings


Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Stockholders' Equity

Income Statement ($ Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($ Quarter)

Operating, Investing, Financing

Comparables ($ Annual) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Ryanair Holdings RYAA -1,000 13,250,700,000,000 8,035,800,000,000 0 0 0 0 -34,900,002,000
Lingo Media LMDC -1,000 1,302,004,000 743,410,000 0 0 0 0 -1,000
Apollo Education APOL 1,063,294,900,000 1,955,243,000,000 886,324,000,000 2,000,328,000,000 0 -19,719,000,000 62,995,000,000 579,271,900,000
China Crawfish CACA -1,000 2,499,000 0 0 0 -4,278,000 -4,278,000 -2,501,000
Mirenco MREO
Granite Real Estate GRP
Weyland Tech WEYL -1,000 10,602,385,000 5,279,803,000 29,462,263,000 -957,570,000 -4,242,435,000 -4,098,835,000 -5,302,921,000
Baynon BNON -1,000 11,303,000 144,518,000 0 0 -20,995,000 -19,951,000 98,696,000
Green Planet Bio Engineering GPLB 3,000,960,000 0 271,686,000 0 0 -38,208,000 -38,208,000 3,000,959,000
G-Mes Holdings GMES -1,000 1,262,407,000 812,133,000 651,687,000 608,846,000 66,711,000 140,706,000 -30,825,000
Immune Therapeutics IMUN 0 23,672,000 12,552,994,000 0 33,986,000 -5,080,179,000 -5,078,622,000 -21,398,000
Therapeutic Solutions TSOI 0 367,163,000 1,851,159,000 13,260,000 10,130,000 -1,579,387,000 -1,235,683,000 481,264,000
Blue Sphere BLSP 894,407,000 43,956,000,000 86,868,000,000 7,950,000,000 2,700,000,000 -14,453,000,000 -14,295,000,000 8,802,407,000
Frontier Digital Media Group FDMG -1,000 5,245,000 30,791,000 31,784,000 0 -29,127,000 -29,127,000 -3,427,000
Stem Holdings STEMH -1,000 40,803,014,000 5,702,703,000 957,741,000 363,932,000 -8,070,014,000 -7,496,304,000 -5,453,599,000
MWF Global MWF -1,000 -1,000 -1,000 125,000 0 -34,156,000 -34,156,000 -569,000
Clean Coal Technologies CCTC -1,000 27,229,000 16,748,864,000 0 0 -5,795,085,000 -3,051,616,000 893,654,000
SpringWorks SWTX
Brighthouse Life Insurance Co of Ny BHNY -1,000 9,065,749,000,000 8,029,864,000,000 236,819,000,000 0 0 2,514,000,000 -190,199,002,000
Imine JRVS 5,585,460,000 2,105,000 589,753,000 0 0 -1,527,105,000 -1,527,105,000 6,083,355,000

Balance Sheet ($)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash419,0004,034,000644,0004,436,0003,387,0007,686,0003,137,0002,137,0001,138,0002,738,0002,798,0002,498,000598,0004,198,000625,0001,725,000625,000475,000525,000425,000315,000178,00098,00083,000168,000253,000243,000
Accounts Receivable
Inventory
PP&E
Assets419,0004,034,000644,0004,436,0003,387,0007,686,0003,137,0002,137,0001,138,0002,738,0002,798,0002,498,000598,0004,198,000625,0001,725,000625,000475,000525,000425,000315,000178,00098,00083,000168,000253,000243,000
Accounts Payable2,658,000003,500,000003,400,0003,475,0001,100,0001,100,0003,900,0001,200,000
Long-Term Debt
Liabilities102,131,000116,706,000121,888,000133,379,000139,989,000152,848,000154,298,000159,148,000164,098,000174,756,000181,152,000186,628,000190,404,000202,590,000205,156,000212,167,000216,993,000225,886,000231,920,000237,913,000243,936,000253,172,000259,433,000265,784,000272,259,000281,653,000288,317,000
Stockholders' Equity-101,712,000-112,672,000-121,244,000-128,943,000-136,603,000-145,162,000-151,161,000-157,011,000-162,960,000-172,018,000-178,354,000-184,130,000-189,806,000-198,392,000-204,531,000-210,442,000-216,368,000-225,411,000-231,395,000-237,488,000-243,621,000-252,994,000-259,335,000-265,701,000-272,091,000-281,400,000-288,074,000
Income Statement ($)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue00000000000000000000000
Cost of Revenue
Gross Profit
R&D
SG&A
Tax00000000000000000000000
Net Income-10,960,000-8,572,000-7,699,000-8,559,000-5,999,000-5,850,000-5,949,000-9,058,000-6,336,000-5,776,000-8,586,000-6,139,000-5,911,000-9,043,000-5,984,000-6,093,000-6,133,000-9,373,000-6,341,000-6,366,000-6,390,000-9,309,000-6,674,000
Cash Flow ($)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-885,000-3,390,000-3,708,000-1,049,000-4,549,000-1,000,000-999,000-3,400,000-1,490,000-300,000-1,900,000-400,000-3,573,000-1,900,000-150,000-4,450,000-1,100,000-1,110,000-137,000-4,580,000-15,000-1,115,000-1,115,000-3,910,000
Cash Investing0000000000000000000000000
Cash Financing4,500,00007,500,00004,300,0000005,000,0001,550,000004,000,00003,000,00004,500,0001,000,0001,000,00004,500,00001,200,0001,200,0003,900,000